1Tatyana A Grushko,M Anne Blackwood,Phil L Schumm,et al.Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers[J].Cancer Rearch,2002,62:1481 -1488. 被引量：1
2Coussens L,Yang-Feng TL,Liao YC,et al.Tyrosine kinase receptor with extensive homology to EGC receptor shares chromosomal location with neu oncogene[J].Science,1985,230:1132-1139. 被引量：1
3Slamon DJ,Clark GM,Wong SG,et al.Human breast cancer:correlation of relapse and survival with amplification of the HER-2/neu oncogene[J].Science,1987,235:177-181. 被引量：1
4Van de Vivjer MJ,Peterse JL,Mooi WJ,et al.Neu-protein overexpression in breast cancer[J].N Engl J Med,1988,319:1239-1245. 被引量：1
5Heintz NH,Leslie KO,Rogers LA,et al.Amplification of the c-erb B-2 oncogene in prognosis of breast adenocarcinoma[J].Arch Pathol Lab Med,1990,114:160-163. 被引量：1
6Jeffrey S.Ross,Jonathan A.Fletcher.The HER-2/neu Oncogene in breast cancer:prognostic factor,predictive factor,and target for therapy[J].Stem Ce11,1998,16(6):413 -428. 被引量：1
7Brower FT,Ahmed S,Tartter P,et al.Prognostic variables in invasive breast cancer:Contribution of comedo versus non-comedo in-situ component[J].Ann Surg Oncol,1995,2:440-444. 被引量：1
8DePotter CR,Schelhout AM,Verbeeck P,et al.Neu overexpression correlates with extent of disease in large cell ductal in situ carcinoma of the breast[J].Hum Pathol,1995,26:601-606. 被引量：1
9Azacleh stark,Barbara S.Hulka,Sxott Joens,et al.Her-2/neu amplification in benign breast disease and the risk of subsequent breast cancer[J].Journal of Clinical Oncology,2000,18 (2):267-284. 被引量：1
10Isola JJ,Holli K,Oksa H,et al.Elevated erbB-2 oncoprotein levels in preoperative and follow-up serum samples defined in aggnessive course in patients with breast cancer[J].Cancer,1994,73:652-658. 被引量：1
2Baselga J, Tripathy D, Mendelsohn J, et al, Phase II study of weekly intravenous recombiTmnt humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. JClin Oncol, 1996, 14: 737-744. 被引量：1
3Vogel CL, Cobleigh MA, Tripalhy D, et al. First-line herceptin monolherapy in metastatic breast cancer. Oncology 2001,61 ( Suppl2).37-42. 被引量：1
4Fomier M, Esteva FJ, Seidman AD. Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer. Semin-Oncol,2000, 27: 38-45. 被引量：1
5Baselga J, Norton L, Albanell J, et al. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res, 1998, 58: 2825-2831. 被引量：1
